The innate immune system may be activated around the time of diagnosis of type 1 diabetes (T1D). Components of this system, including cytokines such as interleukin‐1β (IL‐1β) represent potential therapeutic… Click to show full abstract
The innate immune system may be activated around the time of diagnosis of type 1 diabetes (T1D). Components of this system, including cytokines such as interleukin‐1β (IL‐1β) represent potential therapeutic targets for disease modifying therapy.
               
Click one of the above tabs to view related content.